CBDNewsBreaks – InMed Pharmaceuticals (IMLFF) Featured in Forbes Article Discussing Unique Cannabinoid Manufacturing System and Database
InMed Pharmaceuticals (OTCQB: IMLFF) was recently featured in a Forbes article highlighting the company's cannabinoid manufacturing system and database, which is used to map different compounds of cannabinoids to the various diseases they are able to treat. According to the article, InMed’s database appeals to other biotech companies who are now willing to purchase the information. Using its database, InMed has been able to identify two new cannabinoid therapies. Additionally, the company has created a method of biosynthesis for cannabinoids that is comparable to the system used to create synthetic insulin for diabetic patients. The company begins with the cannabinoid…